EUVIMED · CrossrefJournal
Gene Therapy
ISSN 0969-7128 · Springer Science and Business Media LLC
Latest articles
Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials
AAV8-PDE6B with 3’UTR provides rescue of photoreceptor structure and function in the rd10 mouse model of retinitis pigmentosa
Renal CLCN5 gene therapy for Dent disease type 1: local rapamycin immune modulation and age-dependent outcomes with lentiviral and AAV9 vectors
In vivo frataxin expression of a triplex purified minicircle
Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters
Organoids – the future of pre-clinical development of AAV gene therapy for CNS disorders
In vitro and in vivo rescue of dopaminergic neurons in Parkinson’s disease models after Parkin gene therapy
Research progress and development strategies of antibody-oligonucleotide conjugates
Precision rewriting of muscle genetics: therapeutic horizons of base and prime editing in skeletal muscle disorders
Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA’s conclusions from the evaluation of 38 suspected cases
Metadata assessment of non-human primate studies of AAV9 uncovers potential tissue specific variation in expression efficiency
CRISPR-AuNP: physicochemical optimization of a gold nanoparticle platform for cost-effective and modular non-viral gene editing in HSPCs
Therapeutic in vivo genome editing: innovations and challenges in rAAV vector-based CRISPR delivery
HDX-MS reveals pH and temperature-responsive regions on AAV capsids and the structural basis for DNA release
hInGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicity
Dystrophin/mini-dystrophin expression analysis by immunoaffinity liquid chromatography–tandem mass spectrometry after gene therapy for DMD
Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?
Gene therapy restores auditory function and rescues damaged inner hair cells in an aged Vglut3 knockout mouse model
AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects
Identification of AAV variants with improved transduction of human vascular endothelial cells by screening AAV capsid libraries in non-human primates
AAV-mediated MUC5AC siRNA delivery to prevent mucociliary dysfunction in asthma
Gene-based therapy for the treatment of spinal muscular atrophy types 1 and 2 : a systematic review and meta-analysis
A capless hairpin-protected mRNA vaccine encoding the full-length Influenza A hemagglutinin protects mice against a lethal Influenza A infection
Ex vivo machine perfusion as a platform for lentiviral gene delivery in rat livers
Aptamer-targeted anti-miR RNA construct based on 3WJ as a new approach for the treatment of chronic kidney disease in an experimental model
Safety, efficacy, and immunogenicity of a novel IgG degrading enzyme (KJ103): results from two randomised, blinded, phase 1 clinical trials
Incomplete elimination of viral genomes is associated with chronic inflammation in nonhuman primate livers after AAV-mediated gene transfer
Focused ultrasound widely broadens AAV-delivered Cas9 distribution and activity
EUVIMED